Clinical Study
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
Table 3
Adverse events of the RBTM and RATM regimens.
| Adverse events | RBTM () | RATM () | value |
| Diarrhea | 2 (2/0/0) | 6 (5/1/0) | 0.28 | Constipation | 0 (0/0/0) | 0 (0/0/0) | ā | Abdominal pain | 3 (3/0/0) | 7 (5/2/0) | 0.25 | Anorexia | 1 (1/0/0) | 2 (0/1/1) | 0.39 | Nausea | 5 (5/0/0) | 12 (8/2/2) | 0.14 | Vomiting | 6 (6/0/0) | 10 (8/1/1) | 0.46 | Skin rash | 1 (1/0/0) | 2 (0/2/0) | 0.22 | Headache | 1 (1/0/0) | 7 (6/1/0) | 0.08 | Dizziness | 0 (0/0/0) | 8 (3/3/2) | 0.03 | Bad taste | 2 (2/0/0) | 4 (2/2/0) | 0.35 | Fatigue | 2 (2/0/0) | 5 (4/1/0) | 0.40 | Others | 0 (0/0/0) | 4 (3/0/1) | 0.12 |
|
|
Total number of individual adverse events (number of different degrees of adverse events: 1/2/3).
|